Home-based Transcranial Direct Current Stimulation Open Trial for Behavioral and Cognitive Symptoms in Huntington's Disease
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to assess feasibility, acceptability, and safety of providing transcranial direct current stimulation( tDCS) to Huntingtons Disease (HD) patients in the early to middle stages and to assess the efficacy of tDCS for HD-related behavioral, cognitive and other symptoms
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
⁃ confirmed HD mutation carriers
⁃ early (stages 1 and 2) or moderate (stage 3) stages according to Shoulson-Fahn
⁃ exhibit mild to moderate behavioral symptoms, such as clinically diagnosed apathy, irritability, anxiety, depression, aggression and repetition
⁃ stable doses of medications for at least one month
• willingness to participate in the study
Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Erin Stimming, MD
Erin.E.Furr@uth.tmc.edu
(713) 500-7033
Backup
Thiago Macedo e Cordeiro, MD
Thiago.MacedoeCordeiro@uth.tmc.edu
(713) 486-2559
Time Frame
Start Date: 2023-06-21
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 10
Treatments
Experimental: active tDCS
Authors
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston